Synephrine: from trace concentrations to massive consumption in weight-loss.

Synephrine is cited as 'the active component' of plants and dietary supplements used in weight loss. It became one of the most popular stimulants present in weight-loss products after the US Food and Drug Administration had interdicted the use of ephedrine-containing dietary supplements. Synephrine is also a trace amine that can be found in vertebrates and invertebrates. Synephrine acts on several adrenergic and serotonergic receptors and its activity on trace-amine-associated receptors has long been discussed. Synephrine exists in three different positional isomers; however, only p- and m-synephrine have been described in weight-loss products. The alleged effectiveness of synephrine-containing supplements is attributed to the thermogenic effects arising from synephrine's adrenergic stimulation. The growing use of synephrine has raised concerns since it has been accompanied by reports of adverse effects. Cardiac adverse events, including hypertension, tachyarrhythmia, variant angina, cardiac arrest, QT prolongation, ventricular fibrillation, myocardial infarction, and sudden death, have been the most common adverse effects associated with synephrine intake. The mechanisms involved in synephrine-induced cardiotoxicity are still unknown since studies related to its safety are scarce. This review will address general aspects concerning the pharmacology of synephrine, but will focus on the efficacy and toxicity aspects related to the use of synephrine in weight-loss.

[1]  H. Suh,et al.  Characterization of antidepressant-like effects of p-synephrine stereoisomers , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  J. Crowley,et al.  The mammalian metabolism of R‐(‐)‐m‐synephrine , 1983, The Journal of pharmacy and pharmacology.

[3]  P. Evans,et al.  Activities of Octopamine and Synephrine Stereoisomers on Octopaminergic Receptor Subtypes in Locust Skeletal Muscle , 1988, The Journal of pharmacy and pharmacology.

[4]  M. Raggi,et al.  Fast CE analysis of adrenergic amines in different parts of Citrus aurantium fruit and dietary supplements. , 2010, Journal of separation science.

[5]  J. Neuhaus,et al.  Safety and efficacy of citrus aurantium for weight loss. , 2004, The American journal of cardiology.

[6]  R. Limberger,et al.  Screening for in vivo (anti)estrogenic activity of ephedrine and p-synephrine and their natural sources Ephedra sinica Stapf. (Ephedraceae) and Citrus aurantium L. (Rutaceae) in rats , 2008, Archives of Toxicology.

[7]  K. Clauson,et al.  Safety issues associated with commercially available energy drinks. , 2008, Journal of the American Pharmacists Association : JAPhA.

[8]  D. Grandy,et al.  Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. , 2001, Molecular pharmacology.

[9]  H P Rang,et al.  Comprar Rang & Dale's Pharmacology, 7th Edition with STUDENT CONSULT Online Access | Graeme Henderson | 9780702034718 | Churchill Livingstone , 2011 .

[10]  Gerald T. Mangine,et al.  Thermogenic Effect from Nutritionally Enriched Coffee Consumption , 2006, Journal of the International Society of Sports Nutrition.

[11]  P. Watkins,et al.  PHARMACOKINETICS AND DRUG DISPOSITION Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins , 2001 .

[12]  L. Ramón-Laca,et al.  Pharmacological properties of citrus and their ancient and medieval uses in the Mediterranean region. , 2005, Journal of ethnopharmacology.

[13]  M. Ferguson,et al.  STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature. , 2009, Texas Heart Institute journal.

[14]  Barbara E Ainsworth,et al.  Use of nonprescription dietary supplements for weight loss is common among Americans. , 2007, Journal of the American Dietetic Association.

[15]  C. O. Moro,et al.  Obesity and medicinal plants. , 2000, Fitoterapia.

[16]  Corby K. Martin,et al.  Dietary herbal supplements with phenylephrine for weight loss. , 2006, Journal of medicinal food.

[17]  A. Leon,et al.  Elevated levels of circulating trace amines in primary headaches , 2004, Neurology.

[18]  D. Allison,et al.  Dietary supplements in weight reduction. , 2005, Journal of the American Dietetic Association.

[19]  Y. Katsumata,et al.  Oxidation of synephrine by type A and type B monoamine oxidase , 1979, Experientia.

[20]  F. Kusu,et al.  Determination of synephrine enantiomers in food and conjugated synephrine in urine by high-performance liquid chromatography with electrochemical detection. , 1996, Analytical biochemistry.

[21]  M. Soni,et al.  Safety of ephedra: lessons learned. , 2004, Toxicology letters.

[22]  F. Squadrito,et al.  Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat: a preliminary report , 1999 .

[23]  S. Sultan,et al.  Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement. , 2006, Mayo Clinic proceedings.

[24]  S. Stohs Assessment of the adverse event reports associated with Citrus aurantium (bitter orange) from April 2004 to October 2009 , 2010 .

[25]  M. Yuzurihara,et al.  Goshuyuto, a traditional Japanese medicine, and aqueous extracts of Evodiae Fructus constrict isolated rat aorta via adrenergic and/or serotonergic receptors. , 2009, Biological & pharmaceutical bulletin.

[26]  K. Park,et al.  Suppressive Effect on Lipopolysaccharide-Induced Proinflammatory Mediators by Citrus aurantium L. in Macrophage RAW 264.7 Cells via NF-κB Signal Pathway , 2010, Evidence-based complementary and alternative medicine : eCAM.

[27]  Travis A Stephensen,et al.  Ventricular fibrillation associated with use of synephrine containing dietary supplement. , 2009, Military medicine.

[28]  T. Branchek,et al.  Trace amine receptors as targets for novel therapeutics: legend, myth and fact. , 2003, Current opinion in pharmacology.

[29]  M. Joyner,et al.  beta-Receptor agonist activity of phenylephrine in the human forearm. , 2001, Journal of applied physiology.

[30]  A. Grollman Academic perspectives on dietary supplements use: the need for new guidelines. , 2005, Thrombosis research.

[31]  Luyan Zhang,et al.  Determination of hesperidin and synephrine in Pericarpium Citri Reticulatae by capillary electrophoresis with electrochemical detection , 2002, Analytical and bioanalytical chemistry.

[32]  I. Khan,et al.  Effects of synephrine and beta-phenethylamine on human alpha-adrenoceptor subtypes. , 2010, Planta medica.

[33]  B. Nelson,et al.  Determination of para-synephrine and meta-synephrine positional isomers in bitter orange-containing dietary supplements by LC/UV and LC/MS/MS , 2008 .

[34]  M. Yuzurihara,et al.  synephrine, a component of Evodiae Fructus, constricts isolated rat aorta via adrenergic and serotonergic receptors. , 2009, Journal of pharmacological sciences.

[35]  N. Benowitz,et al.  Hemodynamic effects of ephedra-free weight-loss supplements in humans. , 2005, The American journal of medicine.

[36]  S. Durning,et al.  Exercise-induced syncope associated with QT prolongation and ephedra-free Xenadrine. , 2004, Mayo Clinic proceedings.

[37]  I. Khan,et al.  Simultaneous quantification of adrenergic amines and flavonoids in C. aurantium, various Citrus species, and dietary supplements by liquid chromatography. , 2005, Journal of AOAC International.

[38]  M. Hoener,et al.  A renaissance in trace amines inspired by a novel GPCR family. , 2005, Trends in pharmacological sciences.

[39]  A. Fugh-Berman,et al.  Citrus aurantium, an Ingredient of Dietary Supplements Marketed for Weight Loss: Current Status of Clinical and Basic Research , 2004, Experimental biology and medicine.

[40]  F. Carvalho,et al.  Oxidation process of adrenaline in freshly isolated rat cardiomyocytes: formation of adrenochrome, quinoproteins, and GSH adduct. , 2007, Chemical research in toxicology.

[41]  P. But,et al.  Pharmacology and applications of chinese materia medica , 1986 .

[42]  J. Manson,et al.  Annual deaths attributable to obesity in the United States. , 1999, JAMA.

[43]  M. Jann,et al.  Effect of Seville Orange Juice and Grapefruit Juice on Indinavir Pharmacokinetics , 2002, Journal of clinical pharmacology.

[44]  G. Allais,et al.  Biochemistry of neuromodulation in primary headaches: focus on anomalies of tyrosine metabolism , 2007, Neurological Sciences.

[45]  Inès Ouerghemmi,et al.  Juice components and antioxidant capacity of four Tunisian Citrus varieties. , 2011, Journal of the science of food and agriculture.

[46]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[47]  N. Estes,et al.  Variant angina associated with bitter orange in a dietary supplement. , 2006, Mayo Clinic proceedings.

[48]  A. Faigenbaum,et al.  Thermogenic effect of an acute ingestion of a weight loss supplement , 2008, Journal of the International Society of Sports Nutrition.

[49]  J. McGrath,et al.  Activities of octopamine and synephrine stereoisomers on α‐adrenoceptors , 1988 .

[50]  R. Neubig,et al.  International Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature , 2009, Pharmacological Reviews.

[51]  D. Bagchi,et al.  Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview. , 2002, Journal of medicine.

[52]  P. Traldi,et al.  A rapid liquid chromatography electrospray ionization mass spectrometry(n) method for evaluation of synephrine in Citrus aurantium L. samples. , 2005, Journal of agricultural and food chemistry.

[53]  G. Chiellini,et al.  Trace amine‐associated receptors and their ligands , 2006, British journal of pharmacology.

[54]  D. Perez,et al.  The Unique Nature of the Serine Interactions for -Adrenergic Receptor Agonist Binding and Activation (*) , 1996, The Journal of Biological Chemistry.

[55]  I. Khan,et al.  In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto , 2004, Clinical pharmacology and therapeutics.

[56]  R. Limberger,et al.  Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[57]  R. Hoffman,et al.  Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine. , 2005, Mayo Clinic proceedings.

[58]  F. Carvalho,et al.  Development and validation of a GC/IT-MS method for simultaneous quantitation of para and meta-synephrine in biological samples. , 2010, Journal of pharmaceutical and biomedical analysis.

[59]  N. Benowitz,et al.  Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions. , 2008, British journal of clinical pharmacology.

[60]  J. M. Midgley,et al.  β‐Adrenergic activities of octopamine and synephrine stereoisomers on guinea‐pig atria and trachea , 1987, The Journal of pharmacy and pharmacology.

[61]  B. Yamamoto,et al.  Ascorbic acid prevents 3,4‐methylenedioxymethamphetamine (MDMA)‐induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5‐HT , 2001, Synapse.

[62]  C. Strader,et al.  Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. , 1989, The Journal of biological chemistry.

[63]  F. Carvalho,et al.  Cu2+-induced isoproterenol oxidation into isoprenochrome in adult rat calcium-tolerant cardiomyocytes. , 2002, Chemical research in toxicology.

[64]  S. Shimazu,et al.  Pharmacological studies with endogenous enhancer substances: β-phenylethylamine, tryptamine, and their synthetic derivatives , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[65]  A. Mugelli,et al.  α‐SYMPATHOMIMETIC AMINES AND CALCIUM‐MEDIATED ACTION POTENTIALS IN GUINEA‐PIG VENTRICULAR MUSCLE , 1980, British journal of pharmacology.

[66]  R. Niemann,et al.  Determination of ephedrine alkaloids and synephrine in dietary supplements by column-switching cation exchange high-performance liquid chromatography with scanning-wavelength ultraviolet and fluorescence detection. , 2003, Journal of agricultural and food chemistry.

[67]  D. Allison,et al.  Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain? , 2005, International Journal of Obesity.

[68]  D. Nykamp,et al.  Possible Association of Acute Lateral-Wall Myocardial Infarction and Bitter Orange Supplement , 2004, The Annals of pharmacotherapy.

[69]  S. Benvenuti,et al.  Enantioselective LC analysis of synephrine in natural products on a protein-based chiral stationary phase. , 2005, Journal of pharmaceutical and biomedical analysis.

[70]  F. Carvalho,et al.  Copper enhances isoproterenol toxicity in isolated rat cardiomyocytes , 2007, Cardiovascular Toxicology.

[71]  A. Terzic,et al.  On the mechanism of the positive inotropic action of the alpha adrenoceptor agonist, phenylephrine, in isolated rat left atria. , 1991, Journal of Pharmacology and Experimental Therapeutics.

[72]  J. Hengstmann,et al.  [Pharmacokinetics and metabolism of 3H-synephrine (author's transl)]. , 1978, Arzneimittel-Forschung.

[73]  S. Benvenuti,et al.  Chromatographic and electrophoretic methods for the analysis of phenetylamine alkaloids in Citrus aurantium , 2007 .

[74]  N. Limdi,et al.  Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update , 2006, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[75]  J. Betz,et al.  Determination of synephrine in bitter orange raw materials, extracts, and dietary supplements by liquid chromatography with ultraviolet detection: single-laboratory validation. , 2007, Journal of AOAC International.

[76]  M. Soley,et al.  Catecholamine-induced heart injury in mice: differential effects of isoproterenol and phenylephrine. , 2010, Histology and histopathology.

[77]  P. Ambrose,et al.  Blood Pressure and Heart Rate Effects Following a Single Dose of Bitter Orange , 2006, The Annals of pharmacotherapy.

[78]  M. Shara,et al.  A Review of the Safety and Efficacy of Citrus aurantium in Weight Management , 2007 .

[79]  M. Murty,et al.  Products containing bitter orange or synephrine: suspected cardiovascular adverse reactions. , 2004, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[80]  F. Carvalho,et al.  Adrenaline in pro-oxidant conditions elicits intracellular survival pathways in isolated rat cardiomyocytes. , 2009, Toxicology.

[81]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[82]  K. Fontaine,et al.  Health-related quality of life among obese persons seeking and not currently seeking treatment. , 2000, The International journal of eating disorders.

[83]  S. Wise,et al.  Certification of standard reference materials containing bitter orange , 2008, Analytical and bioanalytical chemistry.

[84]  R. Phillips,et al.  Common dietary supplements for weight loss. , 2004, American family physician.

[85]  D. Grandy,et al.  Trace amine-associated receptor 1-Family archetype or iconoclast? , 2007, Pharmacology & therapeutics.

[86]  I. Wainer,et al.  The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein. , 2002, Life sciences.

[87]  T. Tsujita,et al.  Lipolysis induced by segment wall extract from Satsuma mandarin orange (Citrus unshu Mark). , 2007, Journal of nutritional science and vitaminology.

[88]  F. Carvalho,et al.  Structural isomerization of synephrine influences its uptake and ensuing glutathione depletion in rat-isolated cardiomyocytes , 2011, Archives of Toxicology.

[89]  K. Clark,et al.  A comparison of the cardiovascular effects of phenylpropanolamine and phenylephrine containing proprietary cold remedies. , 1991, British journal of clinical pharmacology.

[90]  P. Kovacic,et al.  Unifying mechanism for toxicity and addiction by abused drugs: electron transfer and reactive oxygen species. , 2005, Medical hypotheses.

[91]  F. Firenzuoli,et al.  Determination of adrenergic agonists from extracts and herbal products of Citrus aurantium L. var. amara by LC. , 2002, Journal of pharmaceutical and biomedical analysis.

[92]  G. von Bernuth,et al.  [The effect of oxedrine on the left ventricle and peripheral vascular resistance]. , 1985, Arzneimittel-Forschung.

[93]  M. Cadaldini,et al.  Platelet Aggregation Profiles in Cluster Headache , 2003, Headache.

[94]  B. Yamamoto,et al.  Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. , 2003, Pharmacology & therapeutics.

[95]  C. McGhee,et al.  Analysis of biogenic amines and their metabolites in biological tissues and fluids by gas chromatography-negative ion chemical ionization mass spectrometry (GC-NICIMS). , 1990, Journal of pharmaceutical and biomedical analysis.

[96]  R. Limberger,et al.  Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice. , 2009, Regulatory toxicology and pharmacology : RTP.

[97]  M. Jann,et al.  Seville (sour) Orange Juice: Synephrine Content and Cardiovascular Effects in Normotensive Adults , 2001, Journal of clinical pharmacology.

[98]  K. Klontz,et al.  Consumption of Dietary Supplements Containing Citrus aurantium (Bitter Orange)—2004 California Behavioral Risk Factor Surveillance Survey (BRFSS) , 2006, The Annals of pharmacotherapy.

[99]  J. Smedema,et al.  Coronary spasm and thrombosis in a bodybuilder using a nutritional supplement containing synephrine, octopamine, tyramine and caffeine. , 2008, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[100]  M. Berlan,et al.  Selective activation of β3-adrenoceptors by octopamine: comparative studies in mammalian fat cells , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[101]  S. Benvenuti,et al.  High-performance liquid chromatography methods for the analysis of adrenergic amines and flavanones in Citrus aurantium L. var. amara. , 2004, Phytochemical analysis : PCA.

[102]  V. M. Costa,et al.  Cross-functioning between the extraneuronal monoamine transporter and multidrug resistance protein 1 in the uptake of adrenaline and export of 5-(glutathion-S-yl)adrenaline in rat cardiomyocytes. , 2009, Chemical research in toxicology.

[103]  F. Carvalho,et al.  Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes. , 2009, Toxicology.

[104]  B. Yamamoto,et al.  The effects of methamphetamine on the production of free radicals and oxidative stress. , 1998, The Journal of pharmacology and experimental therapeutics.

[105]  S. Philips,et al.  Kinetic Measurements of the Turnover Rates of Phenylethylamine and Tryptamine In Vivo in the Rat Brain , 1980, Journal of neurochemistry.

[106]  A. Grollman,et al.  Ephedra-Free Is Not Danger-Free , 2003, Science.

[107]  R. Limberger,et al.  Gas Chromatographic Method for Analysis of p-Synephrine in Citrus aurantium L. Products , 2009 .